title: HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women.
authors.affiliation: Department of Epidemiology, Cardiovascular Health Research Unit, University of Washington, Seattle, Washington, USA. C.J.M.Doggen@lumc.nl
authors.forename: C J M
authors.initials: CJ
authors.lastname: Doggen
authors.forename: R N
authors.initials: RN
authors.lastname: Lemaitre
authors.forename: N L
authors.initials: NL
authors.lastname: Smith
authors.forename: S R
authors.initials: SR
authors.lastname: Heckbert
authors.forename: B M
authors.initials: BM
authors.lastname: Psaty
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001779:Blood Coagulation Factors / Q000187:drug effects; D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D017698:Postmenopause; D017035:Pravastatin / Q000494:pharmacology / Q000627:therapeutic use; D012306:Risk; D019821:Simvastatin / Q000494:pharmacology / Q000627:therapeutic use; D020246:Venous Thrombosis / Q000188:drug therapy*
chemical_list: D001779:Blood Coagulation Factors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol; D019821:Simvastatin; D017035:Pravastatin